Replimune Group Files 8-K on Operations
Ticker: REPL · Form: 8-K · Filed: May 22, 2025 · CIK: 1737953
| Field | Detail |
|---|---|
| Company | Replimune Group, Inc. (REPL) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financial-condition, filing
TL;DR
Replimune Group filed an 8-K on May 22, 2025, updating investors on its financial and operational status.
AI Summary
Replimune Group, Inc. filed an 8-K on May 22, 2025, reporting on its results of operations and financial condition. The filing details financial statements and exhibits related to the company's business operations. No specific financial figures or events were detailed in the provided text excerpt.
Why It Matters
This filing provides an update on Replimune Group's financial condition and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting operational and financial information, with no immediate indication of significant risk events.
Key Players & Entities
- Replimune Group, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of earliest event reported
- 001-38596 (company) — Commission File Number
- 82-2082553 (company) — IRS Employer Identification Number
- 500 Unicorn Park Drive Suite 303 Woburn, MA 01801 (address) — Principal executive offices
- (781) 222-9600 (phone_number) — Registrant's telephone number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text excerpt indicates the filing pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits,' but does not specify the actual financial figures or operational details.
What is the exact date of the earliest event reported in this 8-K?
The exact date of the earliest event reported is May 22, 2025.
What is Replimune Group, Inc.'s Commission File Number?
Replimune Group, Inc.'s Commission File Number is 001-38596.
Where are Replimune Group, Inc.'s principal executive offices located?
Replimune Group, Inc.'s principal executive offices are located at 500 Unicorn Park Drive Suite 303, Woburn, MA 01801.
What is the purpose of filing a Form 8-K?
A Form 8-K is a Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 to announce major corporate events that shareholders should know about.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding Replimune Group, Inc. (REPL).